Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

COVID-19 Report for Life Sciences and Health Care Companies

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

Hogan Lovells Publications

COVID-19 D.C. updates

Your guide to the latest Hill developments, news narratives, and media headlines.

News

Buy American EO applies domestic preferences for "essential medicines" and "medical countermeasures"

On August 6, 2020, U.S. President Donald Trump issued his much-anticipated "Buy American" Executive Order (EO), intended to increase and support domestic manufacture and Federal...

News

COVID-19 Report for Life Sciences and Health Care Companies (3 - 7 August 2020)

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

Hogan Lovells Publications

Podcast: Talking the cure

Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the next year, we will touch on cutting edge topics such as...

News

COVID-19 Report for Life Sciences and Health Care Companies (27 - 31 July 2020)

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

Hogan Lovells Publications

Strategic litigation considerations for employers in light of the Virginia Values Act

On July 1, 2020, a number of new employment laws that increase employee rights and protections took effect in Virginia. One major impact of the laws is that employers are likely to have...

News

COVID-19 Report for Life Sciences and Health Care Companies (20 - 24 July 2020)

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

News

FDA extends enforcement discretion period for regenerative medicines, citing COVID-19 challenges

Today, the U.S. Food and Drug Administration (FDA) extended the enforcement discretion period for certain human cell, tissue, and cellular and tissue-based products (HCT/Ps) by an...

Loading data